Results 191 to 200 of about 211,755 (262)
ABSTRACT Microglia play an important role in ischemic stroke (IS). However, the molecular regulatory mechanisms underlying microglial ferroptosis in IS remain incompletely understood. In this study, blood samples were collected from 20 IS patients and 15 healthy volunteers.
Ai‐Xia Song +7 more
wiley +1 more source
Determinants of survival in patients treated with CPX-351 for acute myeloid leukemia. [PDF]
Chiusolo P +10 more
europepmc +1 more source
Transcriptomics-based multi-omics approach for optimizing risk stratification in acute myeloid leukemia. [PDF]
Yang Y +14 more
europepmc +1 more source
Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik +3 more
wiley +1 more source
Is There a Future for CAR-T Therapy in Acute Myeloid Leukemia? [PDF]
Alati C +11 more
europepmc +1 more source
Information Design for Early‐Stage Dose‐Finding Trials
ABSTRACT To enhance enrollment rates in early‐stage dose‐finding clinical trials, we propose an information design approach, where the clinical investigator (CI) commits to an information releasing mechanism (IRM) based on the treatment's uncertain efficacy and toxicity to encourage patients to participate in the trial.
Amin Khademi, Ningyuan Chen
wiley +1 more source
A case report of BCR-ABL(+) acute myeloid leukemia and literature review. [PDF]
Li J, Zheng W, Dong X, Wang J, Liu K.
europepmc +1 more source
Single cell transcriptional evolution of myeloid leukemia of Down syndrome. [PDF]
Trinh MK +24 more
europepmc +1 more source
Genetic analysis of primary lung interdigitating dendritic cell sarcomas
Abstract Interdigitating dendritic cell sarcomas (IDCSs) are rare tumors that commonly arise in the hematopoietic system and rarely outside. The genetic drivers of IDCS carcinogenesis are unknown; therefore, therapeutic options are limited. We investigated somatic gene mutations and copy‐number alterations (CNAs) in nine IDCSs arising in the lung by ...
Mikhail S Ermakov +6 more
wiley +1 more source

